Home / Facilities / 3003965535

LifeSouth Community Blood Centers, Inc. FDA Inspection Record

FEI 3003965535 · Inspections, Form 483s, warning letters and import refusals

LifeSouth Community Blood Centers, Inc. is an FDA-inspected facility (FEI 3003965535) located in Mcdonough, GA, US. RegDataLab tracks 8 FDA inspections at this facility.

Reviewing LifeSouth Community Blood Centers, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check LifeSouth Community Blood Centers, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Apr 30, 2025: No Action Indicated (NAI)
Inspections on record
8 (2 VAI, 6 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 30, 2025No Action Indicated (NAI)No citations listed
May 23, 2023No Action Indicated (NAI)No citations listed
Jan 23, 2019No Action Indicated (NAI)No citations listed
Mar 23, 2017No Action Indicated (NAI)No citations listed
Apr 2, 2015No Action Indicated (NAI)No citations listed
Apr 17, 2013No Action Indicated (NAI)No citations listed
Mar 7, 2011Voluntary Action Indicated (VAI)Adverse Reaction- Reports of Investigations (21 CFR 606.170(a))
Concurrent documentation (21 CFR 606.160(a)(1))
Person performing, test results, interpretation (21 CFR 606.160(a)(1))
Thorough investigations (21 CFR 606.100(c))
Jun 30, 2009Voluntary Action Indicated (VAI)Adverse Reaction- Reports of Investigations (21 CFR 606.170(a))
Required records (21 CFR 606.160(b))
Donor deferral record - each location (21 CFR 606.160(e)(1))
Adverse reaction - Maintenance of Reports (21 CFR 606.170(a))

Facility details

Company
LifeSouth Community Blood Centers, Inc.
Location
Mcdonough, GA (US)
Source
inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.